Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Placebo Controlled, Randomized Study to Evaluate the Safety and Tolerability of INCB019602 Plus Metformin Compared to Metformin Alone in Type 2 Diabetic Subjects

NCT00698789 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT00698789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00698789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Placebo Controlled, Randomized Study to Evaluate the Safety and Tolerability of INCB019602 Plus Metformin Compared to Metformin Alone in Type 2 Diabetic Subjects
Lead sponsor
Incyte Corporation
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2008
Completion date
June 30, 2009
Enrollment
48 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes